How many studies have been conducted on Lobeline?

BiohacksAI has indexed 300 PubMed studies on Lobeline, including 3 randomized controlled trials (RCTs). 13% of studies involve human subjects.

What are the main research areas for Lobeline?

The primary research domains for Lobeline are 🌤️ Mood & Depression, 🧠 Focus & Attention, 🫁 Respiratory. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

Lobeline

An alkaloid that has actions similar to NICOTINE on nicotinic cholinergic receptors but is less potent. It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral vascular disorders, insomnia, and smoking cessation.

300+ PubMed studies analyzed · 3 RCTs · Evidence Score: 41.8

Research Domains

Lobeline has been studied across 18 research domains including 🌤️ Mood & Depression, 🧠 Focus & Attention, 🫁 Respiratory, ❤️ Cardiovascular, 🧘 Stress & Anxiety. The primary research focus is 🌤️ Mood & Depression with 17% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Lobeline, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Mecamylamine

12 shared targets

Dimethylphenylpiperazinium

Dihydro-beta-Erythroidine

Loading evidence profile...

This evidence profile for Lobeline is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.